|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1996-7-25
|
|
pubmed:abstractText |
Promising results of recent clinical trials with a triple drug bio-chemotherapy regimen encouraged its use in patients with renal cell carcinoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
156
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
18-21
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8648791-Adult,
pubmed-meshheading:8648791-Aged,
pubmed-meshheading:8648791-Antimetabolites, Antineoplastic,
pubmed-meshheading:8648791-Antineoplastic Agents,
pubmed-meshheading:8648791-Carcinoma, Renal Cell,
pubmed-meshheading:8648791-Combined Modality Therapy,
pubmed-meshheading:8648791-Female,
pubmed-meshheading:8648791-Fluorouracil,
pubmed-meshheading:8648791-Follow-Up Studies,
pubmed-meshheading:8648791-Humans,
pubmed-meshheading:8648791-Interferon-alpha,
pubmed-meshheading:8648791-Interleukin-2,
pubmed-meshheading:8648791-Kidney Neoplasms,
pubmed-meshheading:8648791-Male,
pubmed-meshheading:8648791-Middle Aged,
pubmed-meshheading:8648791-Remission Induction
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil.
|
|
pubmed:affiliation |
Department of Urology, University of Würzburg Medical School, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
